TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 245 filers reported holding TANDEM DIABETES CARE INC in Q2 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,322,947 | +198.5% | 1,122,915 | +252.6% | 0.02% | +233.3% |
| Q2 2023 | $7,814,199 | -81.3% | 318,427 | +14.7% | 0.01% | -76.9% |
| Q4 2021 | $41,781,000 | -37.6% | 277,581 | -50.5% | 0.03% | -39.5% |
| Q3 2021 | $66,958,000 | +29.0% | 560,883 | +5.2% | 0.04% | +26.5% |
| Q2 2021 | $51,911,000 | +13.8% | 532,969 | +3.1% | 0.03% | +3.0% |
| Q1 2021 | $45,619,000 | -12.8% | 516,934 | -5.4% | 0.03% | -10.8% |
| Q4 2020 | $52,296,000 | -18.4% | 546,576 | -3.2% | 0.04% | -28.8% |
| Q3 2020 | $64,067,000 | +40.8% | 564,467 | +22.7% | 0.05% | +26.8% |
| Q2 2020 | $45,490,000 | +11.0% | 459,866 | -27.8% | 0.04% | -18.0% |
| Q1 2020 | $41,000,000 | +36.3% | 637,137 | +26.3% | 0.05% | +66.7% |
| Q4 2019 | $30,080,000 | – | 504,605 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |